Dr. Jeremy P. Cetnar
Claim this profileOregon Health and Science University
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
23 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
2Lung Cancer
Stage IV
Stage III
RET positive
Affiliated Hospitals
Clinical Trials Jeremy P. Cetnar is currently running
Ramucirumab + Pembrolizumab vs Chemotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Ozuriftamab Vedotin
for Head and Neck Cancer
This is a multi-center, open-label Phase 2 study designed to evaluate the efficacy and safety of BA3021 as monotherapy and combination therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Recruiting1 award Phase 2
More about Jeremy P. Cetnar
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jeremy P. Cetnar has experience with
- Pembrolizumab
- Atezolizumab
- Ramucirumab
- NT-I7
- Carboplatin
- Cisplatin
Breakdown of trials Jeremy P. Cetnar has run
Non-Small Cell Lung Cancer
Lung Cancer
Skin Cancer
Relapse
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy P. Cetnar specialize in?
Jeremy P. Cetnar focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jeremy P. Cetnar currently recruiting for clinical trials?
Yes, Jeremy P. Cetnar is currently recruiting for 4 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Jeremy P. Cetnar has studied deeply?
Yes, Jeremy P. Cetnar has studied treatments such as Pembrolizumab, Atezolizumab, Ramucirumab.
What is the best way to schedule an appointment with Jeremy P. Cetnar?
Apply for one of the trials that Jeremy P. Cetnar is conducting.
What is the office address of Jeremy P. Cetnar?
The office of Jeremy P. Cetnar is located at: Oregon Health and Science University, Portland, Oregon 97239-3098 United States. This is the address for their practice at the Oregon Health and Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.